Out-Licensing and Beyond - Secure Document based processes for the Life Sciences Industry

Add bookmark

Although the business process of “Out-Licensing” is broadly agreed and understood, the way in which different companies go about implementing the process is widely varied. This variation depends to some extent on the size of the company, available resources, the type of product or drug being offered, the product’s development and research stage and of course the internal processes of the company. 

What this whitepaper shows is how you might implement your own Out-Licensing process by comparing two cases with different approaches using the same Brainloop solution. Because Brainloop’s customers can expect not only the absolute confidentiality of their documents, but the confidentiality of their processes, these different experiences are not exactly those of our customers.

Latest Webinars

Pharma IQ's Power List 2022: In conversation with pharma's top leaders

2022-10-18

02:00 PM - 03:00 PM BST

Join us to hear from the most influential people in pharma today, as voted for by you

A post-pandemic 3D view of the patient and supply journey

2022-06-01

04:30 PM - 05:30 PM CET

In this panel discussion with experts from 4G Clinical, THREAD Research and World Courier, learn how...

Discover how targeted radiotherapy induced toxicity can be identified with imaging

2022-04-28

01:00 PM - 02:00 PM EST

This Pharma IQ webinar with AIQ explores how AI-assisted analysis of radiological scans enhances the...

Recommended